Next Article in Journal
Water Intake and Hydration Indices in Healthy European Adults: The European Hydration Research Study (EHRS)
Next Article in Special Issue
Glutamine Modulates Macrophage Lipotoxicity
Previous Article in Journal / Special Issue
Alternate-Day High-Fat Diet Induces an Increase in Mitochondrial Enzyme Activities and Protein Content in Rat Skeletal Muscle
Review

The Intestinal Microbiota in Metabolic Disease

Department of Gastrointestinal Microbiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Arthur-Scheunert-Allee 114-116, 14558 Nuthetal, Germany
*
Author to whom correspondence should be addressed.
Received: 4 December 2015 / Revised: 17 March 2016 / Accepted: 29 March 2016 / Published: 6 April 2016
(This article belongs to the Special Issue Diet and Metabolic Dysfunction)
Gut bacteria exert beneficial and harmful effects in metabolic diseases as deduced from the comparison of germfree and conventional mice and from fecal transplantation studies. Compositional microbial changes in diseased subjects have been linked to adiposity, type 2 diabetes and dyslipidemia. Promotion of an increased expression of intestinal nutrient transporters or a modified lipid and bile acid metabolism by the intestinal microbiota could result in an increased nutrient absorption by the host. The degradation of dietary fiber and the subsequent fermentation of monosaccharides to short-chain fatty acids (SCFA) is one of the most controversially discussed mechanisms of how gut bacteria impact host physiology. Fibers reduce the energy density of the diet, and the resulting SCFA promote intestinal gluconeogenesis, incretin formation and subsequently satiety. However, SCFA also deliver energy to the host and support liponeogenesis. Thus far, there is little knowledge on bacterial species that promote or prevent metabolic disease. Clostridium ramosum and Enterococcus cloacae were demonstrated to promote obesity in gnotobiotic mouse models, whereas bifidobacteria and Akkermansia muciniphila were associated with favorable phenotypes in conventional mice, especially when oligofructose was fed. How diet modulates the gut microbiota towards a beneficial or harmful composition needs further research. Gnotobiotic animals are a valuable tool to elucidate mechanisms underlying diet–host–microbe interactions. View Full-Text
Keywords: intestinal microbiota; obesity; diabetes; metabolic syndrome; energy harvest; diet; absorption; bile acids; low-grade inflammation; SCFA intestinal microbiota; obesity; diabetes; metabolic syndrome; energy harvest; diet; absorption; bile acids; low-grade inflammation; SCFA
Show Figures

Figure 1

MDPI and ACS Style

Woting, A.; Blaut, M. The Intestinal Microbiota in Metabolic Disease. Nutrients 2016, 8, 202. https://0-doi-org.brum.beds.ac.uk/10.3390/nu8040202

AMA Style

Woting A, Blaut M. The Intestinal Microbiota in Metabolic Disease. Nutrients. 2016; 8(4):202. https://0-doi-org.brum.beds.ac.uk/10.3390/nu8040202

Chicago/Turabian Style

Woting, Anni, and Michael Blaut. 2016. "The Intestinal Microbiota in Metabolic Disease" Nutrients 8, no. 4: 202. https://0-doi-org.brum.beds.ac.uk/10.3390/nu8040202

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop